Financials
Financial year 2025
ENDOCRINOLOGIE ES from Harelbeke, company number BE1013732152, closed financial year 2025 with a result of € 15,576 after tax. For that financial year ENDOCRINOLOGIE ES recorded a gross margin of € 24,024 and equity of € 19,743. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.
€ 19,743
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 15,576
Profit after tax over the fiscal year.
€ 24,340
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
5 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 5,702
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 69
Supplier invoices still open on the last day of the fiscal year.
€ 6,925
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to ENDOCRINOLOGIE ES?
What happened at ENDOCRINOLOGIE ES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 15,576. Source: NBB ↗
- New establishment in Kortrijk. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 4,629 in corporate taxes since 2025.
Paid out € 833 in dividends to the owners in total.
A new publication or filing at ENDOCRINOLOGIE ES? We notify you, reason included.
Follow ENDOCRINOLOGIE ESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ENDOCRINOLOGIE ES is Eva Soubry.
Directors
According to the 2025 annual accounts
Eva Soubry
Director
Establishments
Establishment units
Physical locations of this company
Tamboerijnstraat 25
8530 Harelbeke
President Kennedylaan(Kor) 4
8500 Kortrijk
Active since 1 October 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1013.732.152
- VAT number
- BE 1013.732.152
- Registered office
- Tamboerijnstraat 25, 8530 Harelbeke
- Names & denominations
- ENDOCRINOLOGIE ES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 September 2024
- Peppol
- Active · Active since 17 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige vormen van onderwijs